BackPacira BioSciences Overview

Pacira BioSciences Current Cash

Pacira BioSciences's current cash is $250M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$246.96M
↑ 67.33% YoYΔ $99.37M vs prior year quarter

Peer trimmed avg / median

Loading

Pacira BioSciences Current Cash History

Loading

Pacira BioSciences vs. peers: Current Cash Comparison

Loading

Pacira BioSciences Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Pacira BioSciences (PCRX) FAQ

As of the most recent data (September 2026), PCRX shows a current cash of $250M. That compares with $150M in the prior-year period — up 67.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PCRX's current cash is now $250M (was $150M) — a 67.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Pacira BioSciences is outperforming or lagging.

Tracking PCRX's current cash over time shows whether Pacira BioSciences is scaling, shrinking, or reshaping that part of the business. The current reading is $250M That compares with $150M in the prior-year period — up 67.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Pacira BioSciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $250M) with ownership activity and broader fundamentals.

Pacira BioSciences's current cash is $250M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.